DOUBLE-BLIND TRIAL OF TRANSFER-FACTOR VS PLACEBO IN MULTIPLE-SCLEROSIS PATIENTS

被引：0
|
作者：
COLLINS, RC
ESPINOZA, LR
PLANK, CR
EBERS, GC
ROSENBERG, RA
ZABRISKIE, JB
机构：
[1] ROCKEFELLER UNIV,NEW YORK,NY 10021
[2] COLUMBIA UNIV,COLL PHYS & SURG,DEPT NEUROL,NEW YORK,NY 10032
[3] ROYAL VICTORIA HOSP,DIV IMMUNOL & RHEUMATOL,MONTREAL 112,QUEBEC,CANADA
[4] WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63130
来源：
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1978年 / 33卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1 / 11
页数：11
相关论文
共 50 条
  • [21] RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL OF CYCLOSPORINE IN MULTIPLE-SCLEROSIS
    RUDGE, P
    KOETSIER, JC
    MERTIN, J
    BEYER, JOM
    VANWALBEEK, HK
    JONES, RC
    HARRISON, J
    ROBINSON, K
    MELLEIN, B
    POOLE, T
    STOKVIS, JCJM
    TIMONEN, P
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (05): : 559 - 565
  • [22] DOUBLE-BLIND TRIAL OF LINOLEATE SUPPLEMENTATION OF DIET IN MULTIPLE-SCLEROSIS
    MILLAR, JHD
    ZILKHA, KJ
    LANGMAN, MJS
    WRIGHT, HP
    SMITH, AD
    BELIN, J
    THOMPSON, RH
    BMJ-BRITISH MEDICAL JOURNAL, 1973, 1 (5856): : 765 - 768
  • [23] DOUBLE-BLIND TRIAL OF LINOLEIC-ACID IN MULTIPLE-SCLEROSIS
    PATY, DW
    ARCHIVES OF NEUROLOGY, 1983, 40 (11) : 693 - 694
  • [24] DOUBLE-BLIND CONTROLLED TRIAL OF AZATHIOPRINE IN THE TREATMENT OF MULTIPLE-SCLEROSIS
    不详
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (10): : 1387 - 1387
  • [25] A CLINICAL AND IMMUNOLOGICAL STUDY OF THE EFFECTS OF TRANSFER-FACTOR ON MULTIPLE-SCLEROSIS PATIENTS
    LAMOUREUX, G
    COSGROVE, J
    DUQUETTE, P
    LAPIERRE, Y
    JOLICOEUR, R
    VANDERLAND, F
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1981, 43 (03): : 557 - 564
  • [26] FATIGUE THERAPY IN MULTIPLE-SCLEROSIS - RESULTS OF A DOUBLE-BLIND, RANDOMIZED, PARALLEL TRIAL OF AMANTADINE, PEMOLINE, AND PLACEBO
    KRUPP, LB
    COYLE, PK
    DOSCHER, C
    MILLER, A
    CROSS, AH
    JANDORF, L
    HALPER, J
    JOHNSON, B
    MORGANTE, L
    GRIMSON, R
    NEUROLOGY, 1995, 45 (11) : 1956 - 1961
  • [27] OUTCOME MEASURES IN RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND MULTIPLE-SCLEROSIS CLINICAL-TRIAL
    NOSEWORTHY, JH
    OBRIEN, PC
    NAESSENS, JM
    NEUROLOGY, 1994, 44 (04) : A392 - A392
  • [28] TIZANIDINE TREATMENT OF SPASTICITY CAUSED BY MULTIPLE-SCLEROSIS - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    SMITH, C
    BIRNBAUM, G
    CARTER, JL
    GREENSTEIN, J
    LUBLIN, FD
    BAUMEL, B
    HSU, CY
    MURPHY, F
    READER, AT
    SCHAPIRO, RT
    SIBLEY, WA
    STAZIO, A
    TROTTER, JL
    VOLLMER, TL
    WALSHE, TM
    NEUROLOGY, 1994, 44 (11) : 34 - 43
  • [29] HYPERBARIC-OXYGEN AND MULTIPLE-SCLEROSIS - FINAL RESULTS OF A PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    BARNES, MP
    BATES, D
    CARTLIDGE, NEF
    FRENCH, JM
    SHAW, DA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (11): : 1402 - 1406
  • [30] A DOUBLE-BLIND TRIAL OF HYPERBARIC-OXYGEN IN THE TREATMENT OF MULTIPLE-SCLEROSIS
    WOOD, J
    STELL, R
    UNSWORTH, I
    LANCE, JW
    SKUSE, N
    MEDICAL JOURNAL OF AUSTRALIA, 1985, 143 (06) : 238 - 240
12345